Carl Borrebaeck
1 – 10 of 322
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Fluorescence signal enhancement in antibody microarrays using lightguiding nanowires
(
- Contribution to journal › Article
-
Mark
Comprehending the proteomic landscape of ovarian cancer : A road to the discovery of disease biomarkers
(
- Contribution to journal › Scientific review
-
Mark
Identification of a serum biomarker signature associated with metastatic prostate cancer
(
- Contribution to journal › Article
-
Mark
The Value of a New Diagnostic Test for Prostate Cancer : A Cost-Utility Analysis in Early Stage of Development
(
- Contribution to journal › Article
- 2020
-
Mark
Animal-free alternatives and the antibody iceberg
2020) In Nature Biotechnology(
- Contribution to journal › Letter
-
Mark
Psychological resilience and health-related quality of life in Swedish women with newly diagnosed breast cancer
(
- Contribution to journal › Article
-
Mark
Animal-derived-antibody generation faces strict reform in accordance with European Union policy on animal use
(
- Contribution to journal › Letter
-
Mark
Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden
(
- Contribution to journal › Article
-
Mark
Multiplex profiling of serum proteins in solution using barcoded antibody fragments and next generation sequencing
(
- Contribution to journal › Article
-
Mark
Transcriptomic profiling of T-cell populations in non-muscle invasive and muscle invasive bladder cancer.
2020) The Society for Immunotherapy of Cancer's (SITC) 35th annual meeting In Journal for ImmunoTherapy of Cancer 8(Suppl. 3).(
- Contribution to journal › Published meeting abstract